SFA Research Grants
SFA Research Grants support investigators conducting pre-clinical, translational, and clinical research on human sarcomas to advance understanding and improve therapeutic options for patients.
Browse similar grants
Funder: Sarcoma Foundation of America
Due Dates: November 6, 2026, at 11:59 pm EST (LOI) | March 5, 2027 (Invited full applications)
Funding Amounts: Up to $75,000 in total costs for one year (July 1, 2027–June 30, 2028)
Summary: Supports pre-clinical, translational, and clinical research on human sarcomas to improve therapeutic options for patients.
Key Information: All applicants must submit an LOI; only the highest-ranked LOIs receive full-application invitations.
Description
The Sarcoma Foundation of America (SFA) Research Grants are the foundation’s cornerstone research funding program. They support investigations into the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. The program welcomes all areas of sarcoma research, including pre-clinical, translational, and clinical studies, rather than limiting support to a single topic or stage of investigation.
The goal is to support research that produces improved therapeutic options for sarcoma patients. The program also advances SFA’s broader mission to fund research and increase awareness and advocacy for patients and their families. Investigators inside and outside the United States may apply, with awards supporting equipment, supplies, other research expenses, and specified research personnel costs.
